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Abstract
Rat colonic circular muscle, main target of otilonium bromide (OB) spasmolytic activity, is subdivided in an inner and outer
portion. Since the inner one is particularly rich in organelles involved in calcium availability (caveolae, smooth endoplasmic
reticulum, mitochondria), the expression of specific markers (Caveolin-1, eNOS, calreticulin, calsequestrin) in comparison
with the outer portion was investigated. The possible changes of these organelles and related markers, and of muscarinic
receptors (Mr2) were then studied after OB chronic exposition. Rats were treated with 2–20 mg/kg/OB for 10 or 30 days.
Proximal colon was processed by electron microscopy, immunohistochemistry, and western blot. In colon strips the
stimulated contractility response to muscarinic agonist was investigated. The inner portion showed a higher expression of
Caveolin-1 and Mr2, but not of eNOS, calreticulin and calsequestrin, compared to the outer portion. Chronic OB treatment
caused similar ultrastructural and immunohistochemical changes in both portions. Organelles and some related markers
were increased at 10 days; Mr2 expression and muscle contractility induced by methacholine was increased at 30 days. The
present findings: 1) provide new information on the immunohistochemical properties of the inner portion of the circular
layer that are in favour of a role it might play in colonic motility distinct from that of the outer portion; 2) demonstrate that
chronically administered OB interferes with cell structures and molecules responsible for calcium handling and storage, and
modifies cholinergic transmission. In conclusion, chronic OB administration in the colonic circular muscle layer directly
interacts with the organelles and molecules calcium-related and with the Mr2.
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Introduction
Morphological studies in the human, mouse and rat colonic
muscle coat [1–3] showed that the circular muscle layer (CM) can
be distinct in two portions: an outer and thicker one made of
smooth muscle cells (SMC) with typical features, and an inner one
made of a few rows of SMC particularly rich in smooth
endoplasmic reticulum (SER), caveolae and cell-to-cell junctions
with the neighbour pacemaker cells, i.e. the interstitial cells of
Cajal (ICC). All these features might be associated with a peculiar
role of this layer in colonic contractility. To date, no information is
available on qualitative or quantitative differences in specific
markers between these two layers either in physiological or
pathological conditions.
Otilonium bromide (OB) is a quaternary ammonium derivative
used for the treatment of gut motility disorders such as the irritable
bowel syndrome (IBS) [4–6]. In humans, orally administered OB
ameliorates IBS symptoms [7,8] and, by a double-blind placebo-
controlled clinical trial, a beneficial long-lasting effect present also
after its interruption has been recently reported [9].
In vitro studies showed that OB behaves as NK2 receptor
(NK2r) and muscarinic receptor type-2 (Mr2) antagonist and
blocks L- and T-type Ca2+ channels [10,11]. We recently
demonstrated in the rat colon that chronic OB treatment, at
doses and administration time comparable with those utilized in
humans, caused a significant reduction of substance P (SP) in the
myenteric neurons, an increase of the muscular variant of
neuronal nitric oxide synthase (nNOSa), a redistribution of the
L-type Ca2+ channels and hypersensitivity of NK1r in the SMC of
the circular layer [12]. These findings were interpreted as the
consequence of the interaction between the drug and L-type Ca2+
channels. Further, it was reported that 30 days of OB treatment
caused in the rat colon a significant decrease in the neuronal
variant of NOS (nNOSb) in the myenteric plexus associated with
an up-regulation of excitatory neurotransmission in the CM. It
was concluded that chronic OB treatment modifies the balance
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between inhibitory and excitatory neurotransmission [13]. All
these findings indicate that OB owns a broader spectrum of
actions than expected by the in vitro results. In summary, chronic
administration of OB indicates that: i) the colonic CM seems to be
the main target of OB actions; ii) most OB actions are likely
involved in the storage and handling of calcium; and iii) there is an
increase in excitatory neurotransmission. Kinetic experiments
have shown that OB is poorly systemically absorbed and
accumulates in the muscle wall of the large intestine where it
exerts its spasmolytic activity [14,15].
In the present study we investigated the colonic CM of rats
chronically treated with OB, with particular regard to the inner
portion of this layer. At first, the expression of markers related to
the organelles involved in calcium availability, such as caveolae,
SER and mitochondria, was investigated and compared to that of
the outer portion. Second, by transmission electron microscopy
(TEM), we ascertained changes in the features of these organelles;
by immunohistochemistry and western blot, changes in the
expression of markers related to the above organelles and of
muscarinic receptors; by functional experiments, the possible




Male Wistar rats (n = 42; Harlan Laboratories, Udine, Italy)
weighing 19962 g were housed two per cage under standardized
temperature and humidity, kept on a 12 h light/dark cycle with
free access to food and water. The animals were randomly divided
into 5 groups (n = 6–9 animals/group): control group and OB
treated rats. In the treated groups, the drug (2 or 20 mg/kg/day),
that is very soluble in water, was added in drinking water for 10 or
30 days (times chosen on the basis of OB standard treatment in
IBS [15]) and its concentration was adjusted every 2 days
according to the change in body weight and water intake, as
previously described [12]. The control group received only water.
At the end of treatment the animals were sacrificed by CO2
inhalation, the abdomen was opened and samples of the proximal
colon (3–5 cm) quickly removed from 1 cm below the ileocecal
junction. Four tissue samples from the colon of each rat were taken
and randomly assigned to the different procedures: immunohis-
tochemistry, electron microscopy, western blot analysis and
functional studies. All animal procedures were conducted accord-
ing to the Italian Guidelines for Animal Care (DL 116/92) and the
European Communities Council Directive (86/609/EEC). The
study was approved by Menarini Ricerche committee for animal
experimentation and by Italian Minister of Health.
Immunohistochemistry
Full thickness samples of the proximal colon, 1 cm in length,
were randomly taken (10 control rats, 5 treated rats/each dose for
each experimental set) and immediately fixed in 4% paraformal-
dehyde in 0.1 M phosphate buffered saline (PBS) pH 7.4, for 4–
6 h at 4uC. Then they were placed in 30% sucrose in PBS, at 4uC
overnight (ON), embedded in a killik cryostat medium compound
(Bio-Optica, Milan, Italy) and frozen at 280uC. Transverse
sections 8 mm thick were cut with a cryostat and collected on
polylysine coated slides. These sections were then pre-incubated in
1.5% bovine serum albumin (BSA) in PBS, pH 7.4 with 0.5%
Triton X-100, for 20 min at room temperature (RT) to minimize
non-specific binding. The sections were incubated with the
primary antibodies (Table 1) diluted in 0.5% Triton and 1.5%
BSA in PBS ON at 4uC. The following day, the sections were
washed in PBS and then incubated for 2 h at RT in the presence
of Alexa Fluor 48- or 568-conjugated secondary antibodies
(Table 2) diluted 1:333 in 0.5% Triton and 1.5% BSA in PBS.
At the end of incubation, the sections were washed in PBS and
mounted in an aqueous medium (Fluoremount, Sigma, Milan,
Italy). Double labelling was performed as follows: after the first
incubation as described above, the sections were incubated again
with another primary antibody and with its specific secondary
antibody. Negative controls were simultaneously performed
omitting the primary antibody to exclude the presence of non-
specific immunofluorescence staining. The immunoreaction prod-
ucts were observed under an epifluorescence Zeiss Axioskop
microscope (Mannheim, Germany) and were acquired using an
AxioCam, HRm digital camera (Zeiss, Mannheim, Germany).
The fluorescent signal at Axioskop was obtained using a 488- or
568-nm excitation wavelength for green or red immunofluores-
cence, respectively.
Electron microscopy
Tissue was collected from the ascending colon of 5 animals from
each group (controls and OB treated rats/each dose for each
experimental set). We used colonic strips, 1 mm63 mm long.
These strips were immediately cut after the excision and fixed for
6 h in a solution of 2% glutaraldehyde 0.1 M in cacodylate buffer
(pH 7.4). After four rinses in the cacodylate-buffered solution
containing 0.22 M sucrose, the strips were post-fixed for 1 h in 1%
OsO4 in 0.1 M PBS. Dehydration was carried out in graded
ethanol and the strips were then embedded in Epon using flat
moulds to obtain sections with the circular muscle cut in cross-
section. Semi-thin sections, obtained with a LKB-NOVA ultra-
microtome (Stockholm, Sweden), were stained with a solution of
toluidine blue in 0.1 M borate buffer and then observed under a
light microscope to select areas away from the strip edges and with
no apparent signs of mal-fixation or processing artefacts. Ultra-
thin sections of these selected areas were obtained with the LKB
NOVA ultramicrotome using a diamond knife and stained with a
saturated solution of uranyl acetate in methanol (50:50) per
12 min at 45uC, followed by an aqueous solution of concentrated
bismuth subnitrate per 10 min at RT. At least 10–20 ultra-thin
sections from all four strips of each animal were examined under a
JEOL 1010 electron microscope (Tokyo, Japan) and photo-
graphed.
Western blot
Full-thickness samples of the proximal colon (10 control rats, 5
treated rats/each dose for each experimental set) were quickly
minced and homogenized with a tissue homogenizer (Ing.
Terzano, Milan, Italy) in a cold lysis buffer composed of:
10 mM Tris/HCl pH 7.4; 10 mM NaCl; 1.5 mM MgCl2;
2 mM Na2EDTA; 1 mM phenylmethylsulfonyl fluoride (PMSF);
1% Triton X-100 added with 1X Sigmafast Protease Inhibitor
cocktail tables (Sigma-Aldrich, Milan, Italy). Upon centrifugation
at 13000 g for 30 min at 4uC, the supernatants were collected, and
the total protein content was measured spectrophotometrically
using a micro BCA Protein Assay Reagent Kit (Pierce, IL, USA).
Samples (70 mg of proteins per well) and appropriate molecular-
weight markers (Bio-Rad, Hercules, CA) were loaded onto a 7.6%
or 10% SDS-PAGE gel and resolved by standard electrophoresis.
The proteins were then blotted (150 V, 1 h) onto nitrocellulose
membranes (Amersham Biosciences, Cologno Monzese, Italy).
After thorough washings in PBS containing 0.1% Tween-20 (PBS-
T, Sigma- Aldrich), the membranes were treated with blocking
buffer made by 5% non-fat dry milk (Sigma-Aldrich) diluted in
PBS-T for 1 h at RT. Then they were incubated with the primary
OB and Ultrastructure of Colon Circular Muscle
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antibodies ON at 4uC while being stirred (Table 1). The immune
reaction products were revealed by incubating membranes with
appropriated peroxidase-conjugated secondary antibodies (Ta-
ble 2) for 1 h at RT. Immunoreactivity (IR) was detected by an
ECL chemiluminescence reagent (Immune-Star HRP Chemilu-
minescent Kit, Bio Rad, Hercules, CA, USA). In order to
normalize the values of each antibody, all western blot runs were
stripped (Stripping buffer, Thermo scientific, Rockford, IL, USA)
and then immunostained with anti-bactin (Table 1), assuming
actin as the control housekeeping protein. The western blot
immunoreactive bands were revealed using ImageQuant 350
Imager (GE Healthcare, Buckinghamshire, UK).
Functional studies
Segments from proximal colon were transferred into an
oxygenated (95% O2 and 5% CO2) Krebs solution of the
following composition (mM): NaCl 119; NaHCO3 25; KH2PO4
1.2; MgSO4 1.5; KCl 4.7; CaCl2 2.5 and glucose 11. Afterward,
they were opened along the mesenteric border and pinned to a
Sylgard base with the mucosa facing upwards. The mucosal layer
was removed by gentle scraping and two muscle strips (3 mm wide
by 10 mm long) from each segment were cut in the direction of
circular muscle cells.
The strips were placed in a 5-ml organ bath filled with
oxygenated Krebs solution at 37uC and connected to isometric
force transducers (Ugo Basile, VA, Italy) under an initial tension of
10 mN. Mechanical activity was digitally recorded by an Octal
Table 1. List of primary antibodies.
Primary antibodies Host Characteristics Dilution IHC-WB Producer
Anti-Cav-1 Mouse Monoclonal antibody against human
caveolin (aa residues 1–178). Code: 610406
1:250 1:2000 BD Transduction Labs,
Lexington, KY, USA
Anti-eNOS Rabbit Polyclonal antibody against bovin eNOS
(aa residues 598–612). Code: ALX-210-505/1
1:200 1:1000 Alexis, San Diego, CA, USA
Anti-eNOS Rabbit Polyclonal antibody against bovin eNOS
(aa residues 599–613). Code: 482726
1:200 1:1000 Chemicon, Temecula, CA, USA
Anti-Calreticulin Chicken Polyclonal antibody against calreticulin
(aa residues 24–43). Code: PA1-902A
1:200 1:1000 Thermo Scientific, Runcorn,
UK
Anti-Calsequestrin Mouse Monoclonal antibody against rabbit skeletal muscle
sarcoplasmatic reticulum. Code: ab2824
1:200 1:1000 Abcam, Cambridge, UK
Anti-c-kit Rabbit Polyclonal antibody against human c-kit
(aa residues 963–976). Code: A4502
1:300 Dako, Glostrup, Denmark
Anti-aSMA Mouse Monoclonal antibody against N-terminal
synthetic decapeptide of aSMA. Code: A-2547
1:1000 Sigma Chemical Company,
St.Louis, MO, USA
Anti-ChAT Goat Polyclonal antibody against human
placental ChAT. Code: AB144P
1:200 1:1000 Chemicon,Temecula, CA, USA
Anti-Mr2 Rabbit Polyclonal antibody against human M2R
(aa residues 225–356). Code: AMR-002
1:50 Alomone Labs, Jerusalem,
Israel
Anti-Mr2 Rat Monoclonal antibody against M2R
(aa residues 225–359). Code: MAB367
1:400 Chemicon, Temecula, CA, USA
Anti-bactin Rabbit Polyclonal antibody against C-terminal
of b-actin. Code: A-2066
1:20000 Sigma Chemical Company,
St.Louis, MO, USA
doi:10.1371/journal.pone.0103237.t001
Table 2. List of secondary antibodies.
Secondary antibodies Host Characteristics Dilution IHC Producer
Anti-Mouse Goat Conjugated anti-IgG (Fab fragment) 1:333 Invitrogen, San Diego, CA, USA
Anti-Rabbit Goat Conjugated anti-IgG (Fab fragment) 1:333 Jackson ImmunoResearch West Grove, PA, USA
Anti-Chicken Goat Conjugated anti-IgG (Fab fragment) 1:333 Invitrogen, San Diego, CA, USA
Anti-Goat Donkey Conjugated anti-IgG (Fab fragment) 1:333 Invitrogen, San Diego, CA, USA
Secondary antibodies Host Characteristics Dilution WB Producer
Anti-Mouse Goat Conjugated anti-IgG (H+L) 1:15 000 Jackson ImmunoResearch
Anti-Rabbit Goat Conjugated anti-IgG (H+L) 1:15 000 Jackson ImmunoResearch
Anti-Chicken Rabbit Conjugated anti-IgG (H+L) 1:15 000 Jackson ImmunoResearch
Anti-Goat Rabbit Conjugated anti-IgG (H+L) 1:15 000 Jackson ImmunoResearch
Anti-Rat Rabbit Conjugated anti-IgG (H+L) 1:15 000 Jackson ImmunoResearch
doi:10.1371/journal.pone.0103237.t002
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Figure 1. Transmission electron microscopy (TEM) and immunohistochemistry (IHC) of the circular muscle layers in controls. A–C.
TEM. A: An almost continuous monolayer of interstitial cells of Cajal (ICC) covers the innermost portion (icl) of the circular muscle. On the upper side
is the submucosa (SM). Several nerve endings (NE) are close to both the ICC and the icl smooth muscle cells. Bar = 1 mm. B: Detail of the peculiar
morphology of the smooth muscle cells of the icl. Bar = 0.6 mm. C: Detail of the typical morphology of the smooth muscle cells of the outer portion of
the circular muscle layer (ocl). Bar = 0.6 mm. D–F: IHC. D: double labelling with aSMA (green) and c-kit (red). The icl is more intensely labelled with
aSMA than the ocl. The ICC are c-kit-positive (red) and aSMA-negative. E: double labelling with Cav-1 (green) and c-kit (red). The icl is more intensely
labelled with Cav-1 than the ocl. The ICC are either c-kit- or cav-1-positive. F: double labelling with mSMA (red) and Mr2 (green). The icl is more
intensely labelled with Mr2 than the ocl; both layers are aSMA-positive. D–F: Bar = 20 mm.
doi:10.1371/journal.pone.0103237.g001
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Bridge Amplifier connected to a PowerLab/8sp hardware system
(AD Instruments, Bella Vista, MSW, Australia). After a stabiliza-
tion period of 60 min, the spontaneous mechanical activity was
recorded for 15 min and then each preparation was exposed to a
single maximal contractile concentration (1 mM) of the Mr2
receptor agonist methacholine (Sigma-Aldrich, Saint Louis, USA).
All salts used were of analytical grade and purchased from Merck
(Darmstadt, Germany).
Quantitative and statistical analysis
Quantification of caveolae and SER cisternae was done in
micrographs (5 per each group of rats) taken at the same
enlargement (x30.000) and containing at least two SMC profiles.
Cell perimeters were measured (mm) and the number of caveolae
was expressed as mean 6 s.e.m per mm. The number of SER
cisternae was expressed as mean 6 s.e.m per cell profile. The
length of the SER cisternae was also measured and reported as
maximal length and ranging values.
Quantitative analysis of the Cav-1- and eNOS-IR structures was
performed in transverse sections from control and treated
specimens. Digitized images of the muscle wall (4 sections per
animal; 3 animals per group, for a total of 12 sections for each
antibody) were acquired using a 40x objective. Each photograph
was analysed using ImageJ (NIH, Bethesda, USA) to evaluate the
intensity of labelling and quantify the area of IR structures. The
photographs’ threshold values were set in order to analyse the
structures of interest exclusively. Care was taken to maintain the
same threshold in the photographs from the control and OB-
treated animals. For the analysis of the area, the labelling was
converted to a binary image, the number of pixels above threshold
was counted and the percentage area containing IR structures was
calculated. The results are expressed as IR pixels 6 s.e.m.
The quantitative analysis of WB IR bands was performed by
computer-assisted densitometry with each band corresponding to a
single specimen by using the QuantityOne analysis software (Bio-
Rad, Hercules, CA, USA).
Methacholine induced contractile activity was valuated by
means of Chart 4.2 software (AD Instruments). All the results were
analyzed using Graph Pad Prism 5.0 (GraphPad Software, Inc.
San Diego, CA, USA).
Differences between multiple groups of value were examined by
the One-Way ANOVA, followed by the Newman-Keuls multiple
comparison test or unpaired student T test, as appropriate. A value
of p,0.05 was considered statistically significant.
Results
Transmission electron microscopy (TEM)
Controls. At the submucosal border of the CM (Fig. 1A) the
ICC form an almost continuous layer closely apposed to the SMC
of the CM inner portion (icl). The icl cells have an extremely
irregular profile and many processes (Fig. 1A, B) are thinner
(Fig. 1C) and richer in caveolae and cisternae of SER (figs. 1B, 2A)
than those of the outer portion of the CM (ocl). The SER cisternae
are close to plasmalemma and/or caveolae and their maximal
length is 0.28 mm (range: 0.14–0.17 mm) (inset Fig. 2A). The
cytoplasm is filled with thin filaments and mitochondria are
distributed either near the nucleus or at cell periphery. Many
nerve endings, some containing agranular synaptic vesicles and
others granular synaptic vesicles, are close to the icl cells and
intermingled with the ICC.
OB treated rats. At 10 days of OB treatment, with 2 mg/kg
or 20 mg/kg, caveolae and SER cisternae are more numerous
than in controls (Fig. 2A), especially in the icl cells (Fig. 2B). The
SER cisternae, still close to the plasmalemma and the caveolae,
are longer than in controls; their maximal length is 0.63 mm
(range: 0.4–0.5 mm) and 0.52 mm (range 0.35–0.45 mm) in 2 and
20 mg/Kg treated rats, respectively. At 30 days, with both OB
doses, caveolae are still numerous and the cisternae of SER are
even more longer, especially in the cells of the icl (Fig. 2C), and
their maximal length is 0.77 mm (range: 0.35–0.48 mm) and
0.8 mm (range: 0.3–0.45 mm) in 2 and 20 mg/kg treated rats,
respectively (inset Fig. 2C). Statistical analysis demonstrated that
the number of caveolae and of SER cisternae was significantly
increased in all groups of treated animals compared to controls
(Fig. 2D, E).
Noteworthy, at 30 days, the ocl cells show numerous specialized
cell-to-cell contacts (Fig. 3A and inset Fig. 3A), and both the icl
and ocl cells possess large clusters of mitochondria aligned along
the cell periphery (Fig. 3B). In treated animals, no significant
change in caveolae and SER richness is detected in the ICC, and
in synaptic vesicles content and typology of the nerve endings (data
not shown).
Immunohistochemistry and western blot (WB)
Controls. The two subdivisions of the CM are clearly
distinguishable by immunolabelling for their size and shape and
for some differences in immunoreactivity (IR). Indeed, a-smooth
muscle actin-IR (aSMA-IR) (Fig. 1D), Caveolin-1-IR (Cav-1-IR,
figs 1E, 4A) and muscarinic receptor2-IR (Mr2-IR, figs. 1F) are
more intense in the icl cells than in those of the ocl. Conversely,
endothelial nitric oxide synthase-IR (eNOS-IR, Fig. 4D), calreti-
culin-IR (calret-IR, Fig. 5A) and calsequestrin-IR (calseq-IR,
Fig. 5B) show the same intensity in both the icl and ocl cells. To
note, the labelling of aSMA, eNOS and calseq is located in the
cytoplasm (figs.1D, F, 4D, 5B), that of calret and Mr2 is mainly
distributed along the cell periphery (figs. 5A, 6A) and that of Cav-1
is definitively located along the plasmalemma (figs. 1E, 4A).
The ICC are c-kit-, cav-1-, calret-, calseq- (figs. 1D–E, 5A, B)
and eNOS- (data not shown) positive, but are aSMA- (Fig. 1D)
and Mr2-negative (data not shown). Moreover, calseq- and calret-
IR are present also in neurons of the enteric plexuses (data not
shown).
OB treated rats. Immunoreactivitiy of several of the
molecules tested in the icl and ocl cells show changes in their
intensity according to the time and dose of OB exposure.
Molecules involved in calcium handling and storage. At 10 days
of OB treatment, Cav-1-IR and eNOS-IR intensities are increased
Figure 2. Transmission electron microscopy of the inner circular layer (icl). A: Controls. The profile of the cells of the icl is very irregular,
with thin and interconnected ramifications, and the plasmalemma is rich in caveolae (asterisks). Several cisternae of the smooth endoplasmic
reticulum are identifiable close to plasmalemma and caveolae. Inset: detail to evaluate the SER cisternae (asterisks) length and their relationship with
the caveolae and the plasmalemma. B: Rat treated with OB at 2 mg/Kg for 10 days. Caveolae (asterisks) are particularly numerous, as well as the
cisternae of the smooth endoplasmic reticulum. C: Rat treated with OB at 20 mg/Kg for 30 days. Caveolae are still more numerous than in controls
and the cisternae of the smooth endoplasmic reticulum (asterisks) are long and closely apposed to the plasmalemma and the caveolae. Inset: detail
to evaluate the length of the SER cisternae (asterisks), the richness in caveolae and their inter-relationship. A–C and Insets: Bar = 0.3 mm. D:
quantification of the number of SER cisternae per cell profile shows a significant increase in all groups of treated rats compared to controls *p,0.05.
E: quantification of the number of caveolae/mm demonstrates a significant increase in all group of treated rats compared to controls **p,0.01.
doi:10.1371/journal.pone.0103237.g002
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(Fig. 4B, F) in comparison to controls (Fig. 4A, E), in both CM
layers. Quantitative analyses of Cav-1-IR (Fig. 4C) and eNOS-IR
(data not shown), reveals a significant increase (p,0.05) in treated
rats compared to controls. WB analysis for Cav-1 does not display
any difference in the protein expression between control and
treated animals (Fig. 4D), while WB analysis for eNOS demon-
strates an increase that reaches the significance at 2 mg/kg only
(p,0.05) (Fig. 4G). At 30 days of OB treatment, immunohisto-
chemistry (data not shown) and WB analyses (Fig. 4D, G) do not
show any change in Cav-1 and eNOS expression between controls
and treated rats. To note, calret-IR and calseq-IR, either by
immunohistochemistry (data not shown) or WB analysis (Fig. 5C,
D), do not show any significant change after OB treatment.
Molecules involved in excitatory neurotransmission. At 10 days
of OB treatment, no significant change in Mr2- and ChAT-IR is
detected by immunohistochemistry and WB analysis (Fig. 6D, E).
Figure 3. Transmission electron microscopy of the outer circular layer (ocl). Rats treated for 30 days with 20 mg/Kg of OB. A and inset:
Numerous cell-to-cell specialized junctions (asterisks) connect the smooth muscle cells of the ocl to each other. B: Clusters of mitochondria (m) are
aligned along the cell periphery. On the lower side, there is a nerve bundle with numerous nerve endings filled with synaptic vesicles. A, B and inset:
Bar = 0.3 mm.
doi:10.1371/journal.pone.0103237.g003
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To note, WB analysis for Mr2 identifies two distinct bands with
different MW. At 30 days of OB treatment, a significant increase
(p,0.05) in Mr2-IR is found, either by immunohistochemistry
(Fig. 6B) or WB analysis (Fig. 6D). Interestingly, the WB increase
is mainly due to the band with the lighter MW. At 30 days, a small
decrease in ChAT content is observed (Fig. 6E).
Functional experiments
At the end of the stabilization period, the colonic strips from
control and treated rats show a similar resting tension
(2.5760.36 mN (n = 6) and 3.4860.42 mN (n = 6) for controls
and treated rats (20 mg/kg/day for 30 days), respectively (p.
0.05). The Mr2 agonist methacholine induces a tonic contraction
of the circular muscle of the proximal colon in controls and OB
treated rats. In the rats treated with 20 mg/kg for 30 days, the
Figure 4. Immunohistochemistry (IHC) and western blots (WB) for Cav-1 and eNOS. A, B: IHC. Cav-1-immunoreactivity (IR) appears as small
bars located along the plasma membrane of the cells both in the control group (A) and in the rats treated for 10 days (B). The Cav-1-IR in controls is
more intense in the icl respect to the ocl cells. In the treated rats, Cav.1-IR intensity is increased in both layers. C: Quantification of Cav-1 intensity in
the circular muscle layer. A significant increase in Cav-1 intensity is observed after 10 days of treatment (p,0.05).D: WB. Representative bands of Cav-
1-IR and their quantification in control and treated rats. No significant change was seen. E, F: IHC. In controls (E), the eNOS-IR appears as granules
mainly located at the periphery of the smooth muscle cells, with no differences between the icl and the ocl. In the rats treated for 10 days (F), the
labelling intensity is increased in all the cells of the circular muscle (CM). SM: submucosa. G: WB. Representative bands of eNOS-IR and their
quantification in control and treated rats. The increase at 10 days of OB treatment is significant (p,0.05) as compared to controls. A, B, E, F:
Bar = 20 mm.
doi:10.1371/journal.pone.0103237.g004
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contraction induced by methacholine is significantly (p,0.05)
increased compared to controls, the mean values being 12.962.1
and 26.660.5 mN, respectively (n = 6 each group) (Fig. 6F).
Discussion
The present findings demonstrate that in control animals the
inner portion of the CM shows a higher expression of several
markers compared to the outer portion, and is richer in organelles
involved in calcium handling and storage. After chronic OB
treatment, both CM portions undergo similar ultrastructural and
immunohistochemical changes, but with a different time course.
An increase in calcium-related organelles and in Cav-1 and e-
NOS content is observed after 10 days of treatment. A significant
increase in Mr2 expression and in CM contractility after exposure
to a cholinergic agonist is detected in 30 days treated rats.
The inner circular layer (icl)
Ultrastructural studies have already demonstrated that the CM
of the rat proximal colon is subdivided in an inner (icl) and outer
(ocl) portion differing in morphology and size of their SMC [1–3].
However, to date no information was available on possible
differences in the expression of specific markers between the two
portions. The present data showed that the SMC of the icl are
particularly thin, possess several branches by which they contact
each other forming a dense network, and are richer in SER,
caveolae, Cav-1, aSMA and Mr2 than the SMC of the ocl. The
intense Cav-1-IR is likely related to the richness in caveolae. The
intense aSMA-IR might depend on the high content in the thin
contractile filaments that fill the icl cell cytoplasm. The intense
Mr2-IR likely indicates the icl cells are a preferred target of the
neighbouring nerve endings, many of which are ChAT-IR
(Fig. 6D). Conversely, the expression of calret, calseq and eNOS
is similar between the icl and ocl cells. Reasonably, all these
features should reflect a peculiar role of the icl in colonic
contractility. Presently, we do not have enough data to identify this
role and we can only make some hypotheses. The contacts with
the submucosal ICC, i.e. the colonic pacemaker cells, and the
richness in Mr2 make the icl cells the first target of the ICC
electrical activity and excitatory inputs, respectively. When one or
both of these inputs trigger the icl, it contracts forming a tight ring
able to favour, from one side, the water and electrolyte absorption,
and from the other side, together with the outer portion, the
progression of the semisolid content present in the proximal colon.
Structures and molecules involved in calcium storage
and handling
In the rats chronically treated with OB a consistent increase in
caveolae and SER, already appreciable at 10 days, was seen in the
CM, especially in the icl. Moreover, a peculiar peripheral
distribution of mitochondria in all the CM cells and an increase
in specialized cell-to-cell contacts in the ocl were present following
30 days of OB treatment.
Immunohistochemistry and/or WB showed a significant change
in the expression of eNOS and Cav-1 while the other molecules
tested were unchanged. eNOS expression in the SMC has been
previously demonstrated and it has been hypothesized that this
enzyme is bound to the mitochondria handling the calcium storage
and release from these organelles to favour muscular relaxation
[16,17]. Noticeably at 10 days, eNOS expression was markedly
increased. The apparent discrepancy between the reduced calcium
availability and the increase in the calcium-dependent eNOS can
be explained. It has been reported that low levels of NO represent
a stimulus for constitutive NOS transcription and synthesis [16,18]
and that the SMC respond to similar stimuli very rapidly [19]. In
this regard, we previously demonstrated that chronic OB exposure
induced a significant increase in the muscular nNOS at 10 days
Figure 5. Immunohistochemistry (IHC) and western blots (WB) for Calret and Calseq. A and B: IHC. Controls. In (A), double labelling for
Calret (green) and c-kit (red), in (B), double labelling for Calseq (green) and c-kit (red). The smooth muscle cells of both ocl and icl are positive, but no
differences in the IR intensity are present between the two layers. The ICC are double labelled (green and red). Calret-IR appears as granules mainly
distributed at cell periphery, while Calseq-IR is intracytoplasmatic. A, B: Bar = 20 mm. C, D: WB. Repre-sentative bands of Calret-IR (C) and Calseq-IR
(D) and their quantification in control and treated rats. No significant change was seen at any time of duration of OB treatment for both markers.
doi:10.1371/journal.pone.0103237.g005
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[12]. Therefore, this early increase in eNOS might represent the
attempt by the SMC to counteract the decrease in intracellular
calcium availability due to the OB block of calcium entry
[11,20,21]. The return to the eNOS level similar to controls at a
longer time of OB exposition (30 days) might be the consequence
of a sort of adaptation by the cell to the lower level of intracellular
calcium.
A modest, although significant, increase in Cav-1 intensity was
present at 10 days of OB treatment, in agreement with the higher
richness in caveolae seen under TEM. Cav-1 is a structural protein
Figure 6. Immunohistochemistry (IHC) and western blots (WB) for Mr2 and ChAT and contractile effect of muscarinic agonist. In
controls (A), Mr2-IR is granular, mainly distributed at cell periphery and more intense in the icl than in the ocl; in the animals treated for 30 days (B),
the intensity of the IR is increased in the smooth muscle cells of both icl and ocl. C: As in the control, in the 10-day treated animals, there are ChAT-IR
neurons at the myenteric plexus (MP) and nerve fibers within the circular muscle layer (CM), many of which are closely apposed to its submucosal
border. SM: submucosa. A–C: Bar = 20 mm. D: WB analysis for Mr2 identifies two distinct bands with different MW. At 30 days of OB treatment, with
both doses a significant increase in Mr2-IR is found mainly due to the band with the lighter MW. *p,0.01 versus controls and 10 day-treated animals.
E: WB analysis of ChAT demonstrated that after 10 days of treatment there is an increase and after 30 days a decrease; however, none of these
changes is significant. F: Contractile effect induced by a maximal concentration (1 mM) of the muscarinic agonist methacholine on circular muscle
strips of proximal colon from control (black) and otilonium bromide (20 mg/kg/30 days) pre-treated (grey) rats. Each column is the mean6 s.e.m. of 6
experiments.
doi:10.1371/journal.pone.0103237.g006
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linked to the membrane of the caveolae and associated with the L-
type Ca2+ channel [22], one of the main targets of OB [11,20,21].
We have previously demonstrated that chronic treatment with OB
provokes a redistribution of the L-type Ca2+ channels in the
cytoplasm instead of only on the plasmalemma. This redistribution
likely impairs the possibility of association between Cav-1 and L-
type Ca2+ channels and, consequently, in an attempt to favour this
association the cell increases the number of caveolae. This increase
is probably present from the first days of OB treatment and it
remains at least up to 30 days. The discrepancy between
immunohistochemical and WB data that showed no increase in
Cav-1 content could be due to the fact that WB was performed on
fully thick colonic samples comprehensive of the entire muscle coat
plus submucosa and mucosa.
No change in calret and calseq expression was seen at any dose
or at any time during the course of OB treatment in spite of the
increased extension of SER observed under TEM by 10 up to 30
days. According to literature, calret and calseq intracellular
distribution is not limited to the SER but is extended to other
organelles [23]. Indeed, in our hands, the two antibodies labelled
not only the SMC and the ICC but also the neurons, cells poor in
SER. Therefore, the absence of any association between calret-
and calseq-IR and SER extension is not surprising. Also, we
cannot exclude that small changes in these marker expressions are
present in the OB treated rats, but they could be under the
threshold of our revelation system.
Cholinergic system
In the treated animals, Mr2-IR was significantly increased after
30 days. The OB properties to block the Mr2 receptors are well
known [10,21]. Therefore, it is reasonable to hypothesise that the
persistence of the drug induces the cell to counteract the OB block
increasing the receptor expression. In this regard, the functional
results showing a significant increase in muscle contractility to the
muscarinic agonist methacholine compared to controls seem to
indicate a presence of cholinergic hyper-responsiveness. As
confirmation, electrophysiological studies showed that excitatory
JP was significantly larger in treated animals as compared to
controls [13]. The data we presently obtained at 30 days of OB
treatment, such as the numerous mitochondria aligned close to the
plasmalemma, many caveolae, extended SER, numerous and
specialized cell-to-cell junctions, might be interpreted as signs of
SMC adaptation to the presence of the drug aimed at maintaining
its contractile activity.
Interstitial cells of Cajal (ICC)
No ultrastructural or immunohistochemical change was ob-
served in the ICC after OB treatment, although these cells,
similarly to the SMC, are rich in caveolae, SER, mitochondria and
express several of the SMC markers, such as Cav-1 [22,24],
eNOS, [17], calret and calseq [22] and present data. A possible
explanation for these results likely relies on the absence of L-type
Ca2+ channels and Mr2 in the ICC. The findings that the
amplitude and frequency of slow waves [13] and the spontaneous
motility [12] were not modified by OB treatment further underlie
the ICC are not involved in the drug action.
Conclusions
The present findings provide new information on immunohis-
tochemical peculiarities of the icl that are in favour of a specific
role of this portion in the colonic motility, a role that deserves to be
elucidated in further studies. After chronic OB treatment, both
inner and outer CM portions undergo significant ultrastructural
and immunohistochemical changes, thus confirming that the CM
is a preferred OB target.
Several studies have led to the conclusion that the OB block of
the L-type Ca2+ channels constitutes a significant portion of its
therapeutic effects [11,12,19]. However, the inhibition of excit-
atory neurotransmission [25], due to OB antagonism on
neurokinin and muscarinic receptors [10,21], is also considered
important. In regard to the neurokinin-mediated neurotransmis-
sion, we recently demonstrated that chronic OB treatment
modifies the expression and the function of the NK1receptors,
but not of NK2 ones. However, this effect was considered indirect,
due to the prolonged block of the L-type Ca2+ channels induced by
the drug. Therefore, on the basis of the previous and present
findings, we hypothesise that OB, when chronically administered,
directly interacts with two targets, the L-type Ca2+ channels and
the muscarinic receptors.
Intriguingly, the detection of significant ultrastructural changes
in the SMC of the OB treated rats allows speculating that the
effects of this drug might be long lasting, even following its
interruption. In our experimental conditions we cannot evaluate
whether these changes are beneficial or not, but we can reasonably
hypothesise that the SMC adapt well to the lower level of
intracellular calcium.
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